NeutrinoKid
7 minutes ago
From a late 2023 news release, Ab Initio, an Australian will manufacture the lipid nanoparticles for The upcoming research, clinical trials, etc.
Glen Rock, N.J., October 12, 2023/Globe Newswire – RespireRx Pharmaceuticals Inc. (OTC Pink Market: RSPI) (“RespireRx” or the “Company”), f